跳至主要内容
临床试验/CTIS2023-507773-17-00
CTIS2023-507773-17-00进行中(未招募)1 期

Pancreatic head resection or total pancreatectomy with islet autotransplantation (IATx) in patients with periampullary cancer and high risk profile for the development of postoperative pancreatic fistula (POPF) - XandTX Trial - TUD-XandTX-079

Technische Universitat Dresden0 个研究点目标入组 32 人开始时间: 2024年2月9日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • Male and female patients =18 years, Suspicion of or confirmed diagnosis of periampullary cancer and indication for pylorus preserving pancreaticoduodenectomy (PPPD) or Whipple surgery, High risk profile for the development of a postoperative pancreatic fistula (POPF) after pancreatic head resection: soft pancreatic tissue and a pancreatic duct diameter <3mm (pre- and intraoperative confirmation), Written informed consent after clarification

排除标准

  • Patients planned for an additional surgery besides the PPD or Whipple surgery, Simultaneous participation in another interventional clinical trial (up to 4 weeks before enrolment), Addiction or other concomitant diseases, which prevent the participant from understanding and comprehending the scope, nature and potential consequences of the clinical trial, Pregnant or lactating women, Women of childbearing potential, except for women who meet at least one of the following criteria: a) Postmenopausal; b) Post-surgery (6 weeks after bilateral ovariectomy, bilateral salpingectomy with or without a hysterectomy); c) Negative pregnancy test (serum) and the willingness to regularly and correctly use a highly effective contraceptive method (Pearl Index <1%); d) Abstinence; e) Partner’s vasectomy, Any indication that the participant is unlikely to adhere to the protocol (i.e. lack of compliance), Diagnosis of a second primary cancer, Previous organ- or tissue transplant, Known HIV infection (HIV antibody test), Positivity for Anti-HCV, positive anti-HBsAg or anti-HBc, Insulin treated diabetes, Known hypersensitivity towards one of the substances under investigation or its components or substances of similar chemical structure, Individuals, who are dependent from the sponsor, Individuals of vulnerable groups, such as: a) Adults, who are unable to understand the nature, significance and scope of the clinical trial and who are unable to articulate their will accordingly; b)Individuals, who are unable to give consent; c) Individuals, who are institutionalized by court or official order ; d) Individuals listed under exclusion criteria 12 as well as inclusion criteria 1 and 4

研究者

发起方
Technische Universitat Dresden

相似试验